Comparison of the packaging and labeling of Target ClearRx with conventional prescription drug packaging and labeling

Soller, R. William; Lightwood, James

doi:10.1331/japha.2007.06089

Cited by 8 publications

(13 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding the target population of included studies, nine studies involved the general public (laypeople, students, and/or medication users), 9,11,13,14,18,19,[23][24][25] six studies involved healthcare professionals (physicians in two studies, 16,20 nurses in one study, 15 and mixed or unspecified healthcare professionals in three studies 10,12,21 ), and one study involved healthcare providers and laypeople 22 ; in one study, the target population could not be identified. 17 The educational level of individuals was described in seven studies 9,13,18,[22][23][24][25] and only one presented data of difference in the legibility of the labels, with those with higher educational levels having a better understanding. 25 Regarding age groups, except for one study that included a population of older adults, 25 most patients were aged 30 to 50 years.…”

Section: Resultsmentioning

confidence: 99%

“…Regarding interventions that changed the layout of drug labels, as shown in Table 3, most studies recruited laypeople, whereas only one study involved hospital healthcare providers. Three studies evaluated the primary package, 9,12,24 whereas one study evaluated the secondary package. 23 Garnerin et al 12 assessed the impact of changes in the display of drug label information required to correctly interpret the relationship between the concentration data of a drug (mass in milligram, volume in milliliter, and concentration in milligram/milliliter) and its respective label.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Interventions to Reduce Problems Related to the Readability and Comprehensibility of Drug Packages and Labels: A Systematic Review

et al. 2020

View full text Add to dashboard Cite

The aim of the study was to evaluate the effectiveness of interventions designed to reduce problems with readability and comprehensibility in drug labels.Methods: A systematic review of observational and experimental studies was conducted using MEDLINE (via PubMed), Embase, and Scopus databases. Two independent reviewers selected articles and collected data about study design, interventions, and outcomes.Results: Of 1786 studies screened, 17 were included in this systematic review. The main findings were described according to the type of intervention in the drug package or label: color-coded labels (7 studies); changes in information layout (5 studies); changes in font size (3 studies); and interventions involving look-alike/sound-alike (LASA) drugs (3 studies). Color changes were important both for healthcare professionals to improve safety in hospital practice and for medication users to differentiate between the types of insulin. Layout changes were effective and included highlighting key information, such as medication name, dose, and instructions. Increased font size yielded good results in the recognition and identification of medications mainly for the population with impaired vision. This review was limited by the heterogeneity of interventions and populations studied, as well as the small number of high-quality studies, which prevented meta-analysis across any one intervention or outcome. Conclusions:All studies reported positive results for the proposed interventions. In the case of LASA drug names, the use of resources beyond Tall Man lettering (such as color and highlighting) reduced recognition errors, which may contribute to the development of new strategies to improve safety in the use of LASA drugs.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Interventions to Reduce Problems Related to the Readability and Comprehensibility of Drug Packages and Labels: A Systematic Review

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Studies have demonstrated that the literacy level of patients has an impact on their ability to understand directions on a label [15]. Health literacy has increasingly been viewed as a patient safety issue, and lower literacy may contribute to medication errors [16]. Lower literacy and a greater number of prescription medications were independently associated with misunderstanding the instructions on prescription medication labels [17].…”

Section: Discussionmentioning

confidence: 99%

“…It has been demonstrated that patients actually prefer types of packaging and labeling that are designed for safety, are easier to read, and have better organized warnings with larger type size [16]. …”

Section: Discussionmentioning

confidence: 99%

Packaging and Labeling of Pharmaceutical Products Obtained from the Internet

Veronin¹

2011

J Med Internet Res

View full text Add to dashboard Cite

BackgroundFor patients, the prescription container label may be the only source of instructions on how to take their medicines. In the United States, the legal requirements for a prescription label are set by federal law and state statutes. The container should be comparable to that which manufacturers use to package drug products and should preserve a product’s identity, strength, quality, and purity and prevent contamination. Safety features such as a child-resistant closure should be provided. Pharmaceutical products purchased from international online pharmacies are not approved by the Food and Drug Administration (FDA) and may not meet US guidelines for labeling and packaging.ObjectiveThe study objective was to determine whether commonly purchased pharmaceutical products obtained from international online pharmacies are comparable to products dispensed in the United States with regard to labeling and packaging.MethodsDuring March 2006 through January 2007, 41 pharmaceutical oral dosage form samples were obtained from international Internet pharmacy websites for evaluation: 18 generic simvastatin samples, 18 generic amlodipine samples, and 5 generic sildenafil samples. Contents for each package were observed and recorded and comparison of the prescription labeling and packaging of these products was made with prescription labeling and packaging requirements in the United States.ResultsOf the 41 drug products obtained from online pharmacies from 12 different countries, only 1 product (from Canada) would meet both labeling and packaging guidelines for products dispensed in the United States. Of those not meeting the requirements, 7 were dispensed in paper envelopes with label affixed that was either handwritten or typed and contained missing information such as name and address of dispenser, name of prescriber, name of patient, and directions for use. Another 3 products did not have a label affixed to the drug product, but information was printed on a paper document enclosed in the shipping package, while 28 products did not have labels affixed to the drug product. In all, 39 of the 41 drug products’ packaging would not meet the US guidelines. Aside from the Canadian product, only 1 product from Mexico was dispensed in a container that would meet guidelines established in the United States. In total, 35 products were not dispensed in plastic vials but were dispensed in unit dose packages, paper envelopes with loose dosage forms, blister packs of drugs held together with rubber bands, or a combination of these packaging forms.ConclusionsResults suggest that labeling and packaging standards for international generic drug products are not equivalent to labeling and packaging standards in the United States. This suggests dissimilar and substandard distribution processes compared with those in the United States, which in turn presents a challenge to patient comprehension and health literacy and may affect patient adherence to drug treatment regimens. These findings have strong implications for drug product quality, ...

show abstract

“… 72 Strategies for the evaluation of the effectiveness of public health initiatives for AMR in relation to public perceptions, motivations, and behaviours around antimicrobial use are also needed. [73] , [74] , [75] , [76] …”

Section: Cross-cutting Systems Level Considerationsmentioning

confidence: 99%

Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research

Charani

McKee

Ahmad

et al. 2021

The Lancet Regional Health - Europe

View full text Add to dashboard Cite

Addressing the silent pandemic of antimicrobial resistance (AMR) is a focus of the 2021 G7 meeting. A major driver of AMR and poor clinical outcomes is suboptimal antimicrobial use. Current research in AMR is inequitably focused on new drug development. To achieve antimicrobial security we need to balance AMR research efforts between development of new agents and strategies to preserve the efficacy and maximise effectiveness of existing agents. Combining a review of current evidence and multistage engagement with diverse international stakeholders (including those in healthcare, public health, research, patient advocacy and policy) we identified research priorities for optimising antimicrobial use in humans across four broad themes: policy and strategic planning; medicines management and prescribing systems; technology to optimise prescribing; and context, culture and behaviours. Sustainable progress depends on: developing economic and contextually appropriate interventions; facilitating better use of data and prescribing systems across healthcare settings; supporting appropriate and scalable technological innovation. Implementing this strategy for AMR research on the optimisation of antimicrobial use in humans could contribute to equitable global health security.

show abstract

Comparison of the packaging and labeling of Target ClearRx with conventional prescription drug packaging and labeling

Cited by 8 publications

References 0 publications

Interventions to Reduce Problems Related to the Readability and Comprehensibility of Drug Packages and Labels: A Systematic Review

Interventions to Reduce Problems Related to the Readability and Comprehensibility of Drug Packages and Labels: A Systematic Review

Packaging and Labeling of Pharmaceutical Products Obtained from the Internet

Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research

Contact Info

Product

Resources

About